| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Qasim Iftikhar Ahmad last filed a Form 4 in April 2025, as Chief Medical Officer at IOBT. Qasim Iftikhar Ahmad's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 31,350 shares of IOBT. Net of sales, the IOBT filings show accumulation of 31,350 shares.
Qasim Iftikhar Ahmad has 4 Form 4 filings on record from July 2023 to April 2025, all as Chief Medical Officer at IO Biotech (IOBT), 2023–2025.
The 4 reported transactions were 3 option or other derivative awards and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $27K and no sales.
The only open-market purchase was 31,350 shares of IOBT at an average $0.85 on December 23, 2024, about $27K. Twelve months later IOBT was down 21%.
Shares as reported in the last Form 4 for each company; the most recent is from April 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 23, 2024 | IOBT Io Biotech, Inc. | Chief Medical Officer | Buy | 31,350 | $0.85 | $26,553.45 | New | +12.4% | -21.3% |